Back to Devoured - September 21, 2026
DEVOURED
Anthropic is operating a lab that conducts biology experiments

Anthropic is operating a lab that conducts biology experiments

Tech aibiotechresearch TechCrunch
Anthropic has established an internal wet lab in the Bay Area to conduct physical experiments, marking a shift toward hands-on biological validation.
What: Anthropic, led by CEO Dario Amodei, is operating a wet lab to perform fundamental biology research. The company recently acquired biotech startup Coefficient Bio and launched a Life Sciences Verification Program to grant vetted researchers access to its models. This follows a partnership with Novo Nordisk for drug discovery efforts.
Why it matters: This transition from purely computational models to physical wet lab testing signals that AI labs believe large language models require empirical physical feedback to achieve breakthroughs in medicine.
Deep dive
  • Anthropic confirmed it operates a physical wet lab in the Bay Area for fundamental biology.
  • The lab is used to validate model theories through physical experiments.
  • The company acquired Coefficient Bio in April to accelerate these capabilities.
  • The focus is explicitly on fundamental biology, avoiding direct competition with pharmaceutical customers.
  • A new Life Sciences Verification Program provides vetted researchers with advanced model access.
  • Internal leadership, including CEO Dario Amodei, has publicly framed AI as a tool to cure major diseases within the next decade.
  • The company is balancing these scientific ambitions with high-profile warnings regarding potential existential AI risks.
Decoder
  • Wet lab: A laboratory where chemicals, drugs, or other biological matter are handled in liquid solutions or volatile phases, requiring direct physical experimentation rather than purely computer-based simulation.
  • Fundamental biology: Scientific research focused on understanding the core mechanisms of life, often preceding specific drug development or clinical applications.
Original article

Anthropic has a wet biology lab in the Bay Area where it can use its AI models to run physical experiments, it has confirmed to TechCrunch.

AI leaders have been promising that AI is the key to curing human disease. Dario Amodei opined just last week: “I believe that AI could cure most major diseases in the next 5–10 years.” To do that, an LLM would have to have methods to test its theories in real life.

“We believe that to do biology, the final test is still, and will be for a while, in real lab work,” Anthropic’s head of life sciences, Eric Kauderer-Abrams, told Reuters. “We absolutely are doing that today.” He added that the lab operates like most biotech labs: Anthropic conducts some research there while also working with external partners.

This news probably shouldn’t be shocking. Anthropic bought Coefficient Bio, a stealth AI biotech, in April.

While Anthropic declined to give specifics on what the wet lab is working on, it did say the main focus was fundamental biology, not drug discovery.

Anthropic doesn’t want to give the appearance of competing with the pharma industry, where it has numerous major customers and partners (e.g., it just announced a deal to work with Novo Nordisk on joint drug discovery). Anthropic has already faced backlash for launching products perceived to compete with those of its customers.

To that end, Anthropic also launched a Life Sciences Verification Program this week, to give vetted bio researchers access to its most powerful models. It has also published recent reports on some of the research it’s doing to support drug discovery. This includes one report on accelerating protein design and one on uplifting bimolecular modeling.

But the world is still reeling from the resignation of Anthropic researcher Jacob Coxon, who warned that “the people building AI earnestly believe that it could kill us all by the end of the decade.” Anthropic’s own alignment lead gave the odds at greater than 10% that AI could exterminate humanity within the next decade.

The fervor has grown so intense that CEO Dario Amodei published a post last weekend calling on the industry to slow down and institute self-regulation. He has repeatedly called bioterrorism one of AI’s biggest risks.

The juxtaposition of these dire warnings and the wet lab has not gone unnoticed in the tech industry. As investor and AI coding startup founder Chamath Palihapitiya posted on X, somewhat tongue in cheek: “The group behind such hits as: ‘We’re All Going To Die’ and ‘Regulate Me Now’ are building a wet lab in SF. I do not recommend this.”

Explore all 67 articles in today's digest

Fresh dev news, AI-digested daily. Never miss a trend at devoured.fyi